![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2018
Chauhan, Dhruv; Bartok, Eva; Gaidt, Moritz M.; Bock, Florian J.; Herrmann, Jennifer; Seeger, Jens M.; Broz, Petr; Beckmann, Roland; Kashkar, Hamid; Tait, Stephen W. G.; Müller, Rolf und Hornung, Veit
(2018):
BAX/BAK-Induced Apoptosis Results in Caspase-8-Dependent IL-1beta Maturation in Macrophages.
In: Cell Reports, Bd. 25, Nr. 9, P2354-2368.E5
Kappler, Sarah; Karmann, Lisa; Prudel, Cynthia; Herrmann, Jennifer; Caddeu, Giulia; Müller, Rolf; Vollmar, Angelika M.; Zahler, Stefan und Kazmaier, Uli
(2018):
Synthesis and Biological Evaluation of Modified Miuraenamides.
In: European Journal of Organic Chemistry, Nr. 48: S. 6952-6965
Surup, Frank; Chauhan, Dhruv; Niggemann, Jutta; Bartok, Eva; Herrmann, Jennifer; Keck, Matthias; Zander, Wiebke; Stadler, Marc; Hornung, Veit und Müller, Rolf
(2018):
Activation of the NLRP3 Inflammasome by Hyaboron, a New Asymmetric Boron-Containing Macrodiolide from the Myxobacterium Hyalangium minutum.
In: ACS Chemical Biology, Bd. 13, Nr. 10: S. 2981-2988
2017
Viehrig, Konrad; Surup, Frank; Volz, Carsten; Herrmann, Jennifer; Abou Fayad, Antoine; Adam, Sebastian; Köhnke, Jesko; Trauner, Dirk und Müller, Rolf
(2017):
Structure and Biosynthesis of Crocagins: Polycyclic Posttranslationally Modified Ribosomal Peptides from Chondromyces crocatus.
In: Angewandte Chemie-international Edition, Bd. 56, Nr. 26: S. 7407-7410
2016
Beck, Simon; Henß, Lisa; Weidner, Tatjana; Herrmann, Jennifer; Müller, Rolf; Chao, Yu-Kai; Grimm, Christian; Weber, Christopher; Sliva, Katja und Schnierle, Barbara S.
(2016):
Identification of entry inhibitors of Ebola virus pseudotyped vectors from a myxobacterial compound library.
In: Antiviral Research, Bd. 132: S. 85-91
2012
Herrmann, Jennifer; Elnakady, Yasser A.; Wiedmann, Romina M.; Ullrich, Angelika; Rohde, Manfred; Kazmaier, Uli; Vollmar, Angelika M. und Müller, Rolf
(2012):
Pretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapy.
In: PLOS ONE 7(5), e37416 [PDF, 1MB]
In: PLOS ONE 7(5), e37416 [PDF, 1MB]